European Archives - Page 188 of 1448 - European Medical Journal

ESMO

ESMO 2025: DESTINY-Breast11 Trial Results Revealed

The DESTINY-Breast11 phase 3 trial presented at ESMO 2025 revealed that the anthracycline-free neoadjuvant T-DXd-THP regimen achieved a 67.3% pathologic complete response rate.

Mother’s Voice Enhances Development in Premature Babies

Mother’s Voice Enhances Development in Premature Babies

A new trial shows that hearing their mother’s voice helps premature babies build neural connections essential for language.

EACS 2025: Doxy-PEP Cuts Chlamydia and Syphilis Risk in Men Living With HIV

EACS 2025 study shows doxycycline prophylaxis reduced chlamydia and syphilis rates in Swiss men with HIV, with no effect against gonorrhoea.

Barriers to Timely Melanoma Diagnosis in Latino Patients

Barriers to Timely Melanoma Diagnosis in Latino Patients

Many participants reported that a lack of understanding about skin cancer symptoms led to delays in seeking medical help.

Cardiac Troponin I in transgender adults

Changes in Cardiac Troponin I Levels in Transgender Adults

A first-of-its-kind trial reveals how hormone therapy affects Cardiac Troponin I levels in transgender adults.

mCSPC doctor patient

Improving Treatment Intensification in mCSPC

The IMPLEMENT study explored why first-line treatment intensification remains underutilised and how clinicians’ behaviours, beliefs, and environments influence its uptake.

ViiV's bi-monthly HIV injection approved by NICE

Injectable HIV PrEP marks a breakthrough in prevention, providing a new option for patients in England unable to take daily pills.

EACS 2025: Over Half of HIV Diagnoses in Migrants Occur Years Post-Migration

EACS 2025 data show over half of HIV diagnoses among migrants in Switzerland occur post-migration, highlighting need for targeted testing and prevention.

smartphone toothbrush

Smartphone Toothbrush Revolutionises Plaque Detection

Researchers reveal an innovative toothbrush that uses smartphone integration and AI to visualise and reduce dental plaque instantly.

VLA-Induced Psoriasis Remission

Psoriasis, a prevalent chronic inflammatory skin disease affecting 2–3% of the global population,1 poses a significant therapeutic…